Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis
| dc.Affiliation | October University for modern sciences and Arts (MSA) | |
| dc.contributor.author | M El-Lakkany, Naglaa | |
| dc.contributor.author | H El-Maadawy, Walaa | |
| dc.contributor.author | H Seif el-Din, Sayed | |
| dc.contributor.author | A Hammam, Olfat | |
| dc.contributor.author | H Mohamed, Salwa | |
| dc.contributor.author | Ezzat, Shahira M | |
| dc.contributor.author | M Safar, Marwa | |
| dc.contributor.author | Saleh, Samira | |
| dc.date.accessioned | 2019-12-28T09:31:56Z | |
| dc.date.available | 2019-12-28T09:31:56Z | |
| dc.date.issued | 2017 | |
| dc.description | MSA Google Scholar | |
| dc.description.abstract | Objective To investigate the antifibrotic role of rosmarinic acid (RA), a natural polyphenolic compound, on HSCs activation/proliferation and apoptosis in vitro and in vivo. Methods The impact of RA on stellate cell line (HSC-T6) proliferation, activation and apoptosis was assessed along with its safety on primary hepatocytes. In vivo, rats were divided into: (i) normal; (ii) thioacetamide (TAA)-intoxicated rats for 12 weeks; (iii) TAA + silymarin or (iv) TAA + RA. At the end of experiment, liver functions, oxidative stress, inflammatory and profibrogenic markers, tissue inhibitor metalloproteinases type-1 (TIMP-1) and hydroxyproline (HP) levels were evaluated. Additionally, liver histopathology and immunohistochemical examinations of alpha-smooth muscle actin (α-SMA), caspase-3 and proliferation cellular nuclear antigen (PCNA) were determined. Results RA exhibited anti-proliferative effects on cultured HSCs in a time and concentration dependent manner showing an IC50 of 276 μg/mL and 171 μg/mL for 24 h and 48 h, respectively, with morphological reversion of activated stellate cell morphology to quiescent form. It significantly improved ALT, AST, oxidative stress markers and reduced TIMP-1, HP levels, inflammatory markers and fibrosis score (S1 vs S4). Furthermore, reduction in α-SMA plus elevation in caspase-3 expressions of HSCs in vitro and in vivo associated with an inhibition in proliferation of damaged hepatocytes were recorded. Conclusions RA impeded the progression of liver fibrosis through inhibition of HSCs activation/proliferation and induction of apoptosis with preservation of hepatic architecture. | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19700169713&tip=sid&clean=0 | |
| dc.identifier.citation | P. Ramachandran, J.P. Iredale Liver fibrosis: a bidirectional model of fibrogenesis and resolution QJM, 105 (9) (2012), pp. 813-817 CrossRefView Record in ScopusGoogle Scholar [2] F.J. Bohanon, X. Wang, C. Ding, Y. Ding, G.L. Radhakrishnan, C. Rastellini, et al. Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis J Surg Res, 190 (1) (2014), pp. 55-63 ArticleDownload PDFView Record in ScopusGoogle Scholar [3] S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology, 134 (6) (2008), pp. 1655-1669 ArticleDownload PDFView Record in ScopusGoogle Scholar [4] D.A. Brenner Molecular pathogenesis of liver fibrosis Trans Am Clin Climatol Assoc, 120 (2009), pp. 361-368 View Record in ScopusGoogle Scholar [5] L. Atzori, G. Poli, A. Perra Hepatic stellate cell: a star cell in the liver Int J Biochem Cell Biol, 41 (8–9) (2009), pp. 1639-1642 ArticleDownload PDFView Record in ScopusGoogle Scholar [6] P. Hauff, U. Gottwald, M. Ocker Early to phase Ⅱ drugs currently under investigation for the treatment of liver fibrosis Expert Opin Investig Drugs, 24 (3) (2015), pp. 309-327 CrossRefView Record in ScopusGoogle Scholar [7] C. Frenzel, R. Teschke Herbal hepatotoxicity: clinical characteristics and listing compilation Int J Mol Sci, 17 (5) (2016), p. 588 CrossRefGoogle Scholar [8] H.D. Soares The use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development Curr Opin Investig Drugs, 11 (7) (2010), pp. 795-801 View Record in ScopusGoogle Scholar [9] M. Petersen, M.S. Simmonds Rosmarinic acid Phytochemistry, 62 (2) (2003), pp. 121-125 ArticleDownload PDFView Record in ScopusGoogle Scholar [10] X. Chu, X. Ci, J. He, L. Jiang, M. Wei, Q. Cao, et al. Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice Molecules, 17 (3) (2012), pp. 3586-3598 CrossRefView Record in ScopusGoogle Scholar [11] L.P. Gao, H.L. Wei, H.S. Zhao, S.Y. Xiao, R.L. Zheng Antiapoptotic and antioxidant effects of rosmarinic acid in astrocytes Pharmazie, 60 (1) (2005), pp. 62-65 View Record in ScopusGoogle Scholar [12] S.S. Huang, R.L. Zheng Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro Cancer Lett, 239 (2) (2006), pp. 271-280 ArticleDownload PDFView Record in ScopusGoogle Scholar [13] D.O. Moon, M.O. Kim, J.D. Lee, Y.H. Choi, G.Y. Kim Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells Cancer Lett, 288 (2) (2010), pp. 183-191 ArticleDownload PDFView Record in ScopusGoogle Scholar [14] P.O. Seglen Preparation of isolated rat liver cells Methods Cell Biol, 13 (1976), pp. 29-83 ArticleDownload PDFView Record in ScopusGoogle Scholar [15] P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, et al. New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst, 82 (13) (1990), pp. 1107-1112 CrossRefView Record in ScopusGoogle Scholar [16] T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods, 65 (1–2) (1983), pp. 55-63 ArticleDownload PDFView Record in ScopusGoogle Scholar [17] A.F. Aydin, Z. Küskü-Kiraz, S. Doğru-Abbasoğlu, M. Güllüoğlu, M. Uysal, N. Koçak-Toker Effect of carnosine against thioacetamide-induced liver cirrhosis in rat Peptides, 31 (1) (2010), pp. 67-71 ArticleDownload PDFView Record in ScopusGoogle Scholar [18] F.A. Kadir, N.M. Kassim, M.A. Abdulla, W.A. Yehye Hepatoprotective role of ethanolic extract of Vitex negundo in thioacetamide-induced liver fibrosis in male rats Evid Based Complement Altern Med, 2013 (2013), p. 739850 Google Scholar [19] G.D. Gamaro, E. Suyenaga, M. Borsoi, J. Lermen, P. Pereira, P. Ardenghi Effect of rosmarinic and caffeic acids on inflammatory and nociception process in rats ISRN Pharmacol, 2011 (2011), p. 451682 Google Scholar [20] S. Reitman, S. Frankel A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases Am J Clin Pathol, 28 (1957), pp. 56-63 CrossRefView Record in ScopusGoogle Scholar [21] G.L. Ellman Tissue sulfhydryl groups Arch Biochem Biophys, 82 (1) (1959), pp. 70-77 ArticleDownload PDFView Record in ScopusGoogle Scholar [22] H. Ohkawa, N. Ohishi, K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem, 95 (2) (1979), pp. 351-358 ArticleDownload PDFView Record in ScopusGoogle Scholar [23] J.F. Woessner Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid Arch Biochem Biophys, 93 (1961), pp. 440-447 ArticleDownload PDFView Record in ScopusGoogle Scholar [24] L. Li, Z. Hu, W. Li, M. Hu, J. Ran, P. Chen, et al. Establishment of a standardized liver fibrosis model with different pathological stages in rats Gastroenterol Res Pract, 2012 (2012), p. 560345 Google Scholar [25] H.W. Shen, L. Yi, X.M. Wang, M.J. Yao, J.W. Deng, J.Z. Fang, et al. Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance Ai Zheng, 23 (2) (2004), pp. 181-184 View Record in ScopusGoogle Scholar [26] H.M. Atta, A. Al-Hendy, S.A. Salama, O.G. Shaker, O.A. Hammam Low dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation Liver Int, 29 (7) (2009), pp. 1022-1030 CrossRefView Record in ScopusGoogle Scholar [27] Y. Lu, L.Y. Foo Rosmarinic acid derivatives from Salvia officinalis Phytochemistry, 51 (1999), pp. 91-94 ArticleDownload PDFView Record in ScopusGoogle Scholar [28] E. Madrigal-Santillan, E. Madrigal-Bujaidar, I. Alvarez-Gonzalez, M.T. Sumaya-Martínez, J. Gutiérrez-Salinas, M. Bautista, et al. Review of natural products with hepatoprotective effects World J Gastroenterol, 20 (40) (2014), pp. 14787-14804 CrossRefView Record in ScopusGoogle Scholar [29] G.W. Dryden, M. Song, C. McClain Polyphenols and gastrointestinal diseases Curr Opin Gastroenterol, 22 (2) (2006), pp. 165-170 CrossRefView Record in ScopusGoogle Scholar [30] L.W. Chong, Y.C. Hsu, Y.T. Chiu, K.C. Yang, Y.T. Huang Antifibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats J Biomed Sci, 13 (3) (2006), pp. 403-418 CrossRefView Record in ScopusGoogle Scholar [31] Y.C. Hsu, Y.T. Chiu, C.Y. Lee, C.F. Wu, Y.T. Huang Anti-fibrotic effects of tetrandrine on bile-duct ligated rats Can J Physiol Pharmacol, 84 (10) (2006), pp. 967-976 View Record in ScopusGoogle Scholar [32] P. Muriel, Y. Rivera-Espinoza Beneficial drugs for liver diseases J Appl Toxicol, 28 (2) (2008), pp. 93-103 CrossRefView Record in ScopusGoogle Scholar [33] J.J. Zhang, Y.L. Wang, X.B. Feng, X.D. Song, W.B. Liu Rosmarinic acid inhibits proliferation and induces apoptosis of hepatic stellate cells Biol Pharm Bull, 34 (3) (2011), pp. 343-348 CrossRefView Record in ScopusGoogle Scholar [34] C.A. de la Lastra, I. Villegas Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications Biochem Soc Trans, 35 (Pt 5) (2007), pp. 1156-1160 View Record in ScopusGoogle Scholar [35] S.C. Hsieh, C.H. Wu, C.C. Wu, J.H. Yen, M.C. Liu, C.M. Hsueh, et al. Gallic acid selectively induces the necrosis of activated hepatic stellate cells via a calcium-dependent calpain I activation pathway Life Sci, 102 (1) (2014), pp. 55-64 ArticleDownload PDFView Record in ScopusGoogle Scholar [36] Y.J. Chang, S.L. Hsu, Y.T. Liu, Y.H. Lin, M.H. Lin, S.J. Huang, et al. Gallic acid induces necroptosis via TNF-α signaling pathway in activated hepatic stellate cells PLoS One, 10 (3) (2015), p. e0120713 CrossRefGoogle Scholar [37] T.A. Ajith, U. Hema, M.S. Aswathy Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status Food Chem Toxicol, 45 (11) (2007), pp. 2267-2272 ArticleDownload PDFView Record in ScopusGoogle Scholar [38] O. Lukivskaya, E. Patsenker, R. Lis, V.U. Buko Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal Eur J Clin Investig, 38 (5) (2008), pp. 317-325 CrossRefView Record in ScopusGoogle Scholar [39] H. Sugino, N. Kumagai, S. Watanabe, K. Toda, O. Takeuchi, S. Tsunematsu, et al. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis J Gastroenterol Hepatol, 23 (12) (2008), pp. 1909-1916 CrossRefView Record in ScopusGoogle Scholar [40] Y. Wen, D. Feng, H. Wu, W. Liu, H. Li, F. Wang, et al. Defective Initiation of liver regeneration in osteopontin-deficient mice after partial hepatectomy due to insufficient activation of IL-6/stat3 pathway Int J Biol Sci, 11 (10) (2015), pp. 1236-1247 CrossRefView Record in ScopusGoogle Scholar [41] M.K. Tsai, Y.L. Lin, Y.T. Huang Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats Toxicol Appl Pharmacol, 242 (2) (2010), pp. 155-164 ArticleDownload PDFView Record in ScopusGoogle Scholar [42] T.C. Weng, C.C. Shen, Y.T. Chiu, Y.L. Lin, Y.T. Huang Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats Phytother Res, 26 (3) (2012), pp. 344-353 View Record in ScopusGoogle Scholar [43] T. Kisseleva, D.A. Brenner Mechanisms of fibrogenesis Exp Biol Med, 233 (2) (2008), pp. 109-122 View Record in ScopusGoogle Scholar [44] A.R. Bassiouny, A.Z. Zaky, S.A. Abdulmalek, K.M. Kandeel, A. Ismail, M. Moftah Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells Int J Clin Exp Pathol, 4 (7) (2011), pp. 692-707 View Record in ScopusGoogle Scholar [45] E. Borkham-Kamphorst, C.R. van Roeyen, T. Ostendorf, J. Floege, A.M. Gressner, R. Weiskirchen Pro-fibrogenic potential of PDGF-D in liver fibrosis J Hepatol, 46 (6) (2007), pp. 1064-1074 ArticleDownload PDFView Record in ScopusGoogle Scholar [46] J. Zhou, D.W. Zhong, Q.W. Wang, X.Y. Miao, X.D. Xu Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity World J Gastroenterol, 16 (26) (2010), pp. 3330-3334 CrossRefView Record in ScopusGoogle Scholar [47] F. Tacke, R. Weiskirchen Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques Expert Rev Gastroenterol Hepatol, 6 (1) (2012), pp. 67-80 CrossRefView Record in ScopusGoogle Scholar [48] A.M. Gressner, R. Weiskirchen Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-b as major players and therapeutic targets J Cell Mol Med, 10 (1) (2006), pp. 76-99 CrossRefView Record in ScopusGoogle Scholar [49] E. Gabele, D.A. Brenner, R.A. Rippe Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell Front Biosci, 8 (2003), pp. d69-77 View Record in ScopusGoogle Scholar [50] S. Tsukada, C.J. Parsons, R.A. Rippe Mechanisms of liver fibrosis Clin Chim Acta, 364 (1–2) (2006), pp. 33-60 ArticleDownload PDFView Record in ScopusGoogle Scholar [51] M.E. Guicciardi, G.J. Gores Apoptosis as a mechanism for liver disease progression Semin Liver Dis, 30 (4) (2010), pp. 402-410 CrossRefView Record in ScopusGoogle Scholar [52] A.M. Preaux, M.P. D'Ortho, M.P. Bralet, Y. Laperche, P. Mavier Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2 Hepatology, 36 (3) (2002), pp. 615-622 ArticleDownload PDFView Record in ScopusGoogle Scholar [53] X.W. Liu, M.M. Bernardo, R. Fridman, H.R. Kim Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway J Biol Chem, 278 (41) (2003), pp. 40364-40372 View Record in ScopusGoogle Scholar [54] T. Nakajima, K. Kagawa, K. Ueda, T. Ohkawara, H. Kimura, M. Kakusui, et al. Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues J Gastroenterol, 29 (4) (1994), pp. 450-454 View Record in ScopusGoogle Scholar | en_US |
| dc.identifier.doi | https://doi.org/10.1016/j.apjtm.2017.05.012 | |
| dc.identifier.other | https://doi.org/10.1016/j.apjtm.2017.05.012 | |
| dc.identifier.uri | https://cutt.ly/dtwk90G | |
| dc.language.iso | en | en_US |
| dc.publisher | sciencedirect | en_US |
| dc.relation.ispartofseries | Asian Pacific journal of tropical medicine;Volume 10, Issue 5, May 2017, Pages 444-453 | |
| dc.subject | Hepatic fibrosis | en_US |
| dc.subject | Hepatic stellate cells | en_US |
| dc.subject | Rosmarinic acid | en_US |
| dc.subject | Apoptosis | en_US |
| dc.subject | Proliferation | en_US |
| dc.subject | Profibrogenic markers | en_US |
| dc.title | Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis | en_US |
| dc.type | Article | en_US |